Jazz Pharmaceuticals【JAZZ】株式ニュース

名称	銘柄コード	市場	種別
Jazz Pharmaceuticals PLC	JAZZ	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	5.73	5.39%	112.05	09:00:00

始値	安値	高値	終値	前日終値
105.92	105.56	113.345	112.05	106.32

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/08	05:44	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/04	05:28	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2024/6/01	21:05	PRNUS	Jazz Pharmaceuticals Presents Overall Survival and Longer..
2024/6/01	06:01	EDGAR2	Form 8-K - Current report
2024/5/30	20:30	PRNUS	Jazz Pharmaceuticals Showcases Pioneering Research in Sleep..
2024/5/30	05:15	PRNUS	Jazz Pharmaceuticals to Participate in Upcoming June..
2024/5/29	20:45	PRNUS	Zanidatamab Granted Priority Review for HER2-Positive..
2024/5/22	21:00	PRNUS	Jazz Pharmaceuticals Announces Collaboration with Life..
2024/5/08	06:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/02	05:10	PRNUS	Jazz Pharmaceuticals to Participate in the BofA Securities..
2024/5/02	05:05	PRNUS	Jazz Pharmaceuticals Announces First Quarter 2024 Financial..
2024/4/25	05:05	PRNUS	Jazz Pharmaceuticals to Present Data Across Growing Oncology..
2024/4/18	05:15	PRNUS	Jazz Pharmaceuticals to Report 2024 First Quarter Financial..
2024/4/10	20:45	PRNUS	Jazz Pharmaceuticals to Showcase Expansive Neuroscience..
2024/4/02	20:30	PRNUS	Jazz Pharmaceuticals Completes Zanidatamab Biologics License..
2024/3/13	05:15	PRNUS	Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on..
2024/3/09	08:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/08	11:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/08	11:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/08	11:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/08	11:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/08	08:09	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/06	09:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	09:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	09:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	09:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	09:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	09:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	09:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	09:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	09:14	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/3/02	05:11	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/29	06:06	EDGAR2	Form 8-K - Current report
2024/2/29	06:05	PRNUS	Jazz Pharmaceuticals Announces Full Year and Fourth Quarter..
2024/2/27	21:45	EDGAR2	Form 8-K - Current report
2024/2/27	21:45	PRNUS	Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board..
2024/2/21	21:46	EDGAR2	Form 8-K - Current report
2024/2/21	21:45	PRNUS	Jazz Pharmaceuticals Appoints Philip Johnson as Chief..
2024/2/21	06:15	PRNUS	Jazz Pharmaceuticals to Participate in Upcoming March..
2024/2/15	06:15	PRNUS	Jazz Pharmaceuticals to Report 2023 Full Year and Fourth..
2024/2/07	16:00	PRNUS	Jazz Pharmaceuticals Enters Definitive Agreement with Redx..
2024/1/26	07:01	EDGAR2	Form 8-K - Current report
2024/1/24	23:46	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/20	08:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	08:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	08:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	08:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	08:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/08	21:45	EDGAR2	Form 8-K - Current report
2023/12/22	06:05	PRNUS	Jazz Pharmaceuticals Provides Update on Phase 2 Trial of..